Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?
about
Antiviral T-cell therapyInducible apoptosis as a safety switch for adoptive cell therapySeeing stem cells at work in vivo.Suicide genes: monitoring cells in patients with a safety switch.Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cells.The past, present, and future of adoptive T cell therapy.Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene.[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.Novel application of lentiviral vectors towards treatment of graft-versus-host disease.Progress and prospects: graft-versus-host disease.Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks.Noninvasive cell-tracking methods.Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.Current status of ex vivo gene therapy for hematological disorders: a review of clinical trials in Japan around the world.Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts.
P2860
Q27028006-B32373B9-989E-4784-9D72-9174A2B9BABFQ29617710-1E2EE6D9-0160-4671-8C29-1644105D5633Q30420004-FBCF4AEE-8C3A-4A18-973D-80319BA68F39Q34462056-9797F76C-AD83-4803-AA99-0662BCC1DE28Q35531265-19662EE5-7CB5-42EF-B445-D747506B7BA9Q36306644-E632C435-55D2-4FD3-845A-0609139FE959Q36583196-17E19AB5-2FE6-4180-9E50-19933269F7E3Q36756712-E0CB31E2-40EA-4023-9B96-124B63F85967Q37489887-8598DCCE-5699-4D96-BE68-34A902D4C024Q37761297-FF07653C-1A58-4E0D-924A-5827CB9FE643Q37849773-07C08BF8-D03F-4951-A2C2-36D80C3F4AB3Q37938642-78707839-5CB8-4C11-9B50-C8F26A218B99Q38595264-24189531-75DC-4651-B1B7-A203F934ADBEQ38862302-0CCFD8BE-950B-436F-A2B4-32F41DEE82D0Q38940694-027A93D6-0F3C-4357-AF8E-2D56C46ABCD2Q39037477-B6EC4463-6632-40BD-BEE5-5764524F58B6Q41757334-51F73A27-87EA-46CF-9E93-DCA28E6BFC58Q45885332-FE2FC116-939A-46DB-BD1E-5DDE88233EDE
P2860
Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Early immune response against ...... t: an altered immune response?
@en
Early immune response against ...... t: an altered immune response?
@nl
type
label
Early immune response against ...... t: an altered immune response?
@en
Early immune response against ...... t: an altered immune response?
@nl
prefLabel
Early immune response against ...... t: an altered immune response?
@en
Early immune response against ...... t: an altered immune response?
@nl
P2093
P356
P1433
P1476
Early immune response against ...... t: an altered immune response?
@en
P2093
Bruno Lioure
Christophe Ferrand
Eric Deconinck
Eric Robinet
Jean Marie Certoux
Jean-Yves Cahn
Marina Deschamps
Patricia Mercier-Letondal
Pierre Tiberghien
P304
P356
10.1089/HUM.2007.156
P577
2008-09-01T00:00:00Z